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The Clinical Validation of the Revised 
I ti d P ti t S ti f tincon nence an  a en  a s ac on 
Tools
Assoc Prof Jan Sansoni on behalf     
of the project team
CHSD
Centre for Health Service Development
Refining Continence Measurement Tools
 Used the 2004 SAHOS data to assess the 
psychometric properties of the Urogenital     
Distress Inventory-6 and the Incontinence 
Severity Index
 Assessed the psychometric properties of the 
Wexner Faecal Continence Grading Scale and 
th th f l it i l d d i the o er aeca  ems nc u e  n e survey 
 Psychometric analyses of the data used both 
Classical Test Theory and Modern Test Theory       
(IRT) approaches
 Revised 5 item measures of incontinence were       
derived
 Revised Urinary Incontinence Scale
 Revised Faecal Incontinence Scale
Validating Tools in Clinical Settings    
 This project, funded by DoHA, assessed 
these tools in clinical settings – 11 clinics 
across 4 states  
 Descriptive statistics, reliability, factor 
structure, correlations with other measures 
are examined
 Also examined type of treatment variables –
continence advising physiotherapy , , 
surgical interventions and responsiveness 
to change over time
Revised Urinary Incontinence Scale   
Do you experience and how much are you bothered 
by:
 Urine leakage related to the feeling of urgency?
 Urine leakage related to physical activity coughing     ,  
or sneezing?
 Small amounts of urine leakage?
Responses = not at all, slightly, moderately, greatly 
(0-3)
 How often do you experience urine leakage?
Responses = never to every day/night (0-4)
 How much urine do you lose each time? 
Responses = none, drops, small splashes, more (0-3)
Scores range from 0-16
RUIS : Descriptive Statistics   
N Mean SD Actual RangeFemales
RUIS-SAHOS 1715 2.48 3.33 0 16
RUIS Clin PS Retro* 163 11.56 3.31 1 16   
RUIS Clin Prosp.* 167 10.9 3.18 3 16
N Mean SD
RUIS-SAHOS 1206 0 73 1 97 0 16
Actual RangeMales
. .
RUIS Clin Prosp.* 28 11.07 4.18 0 16
* = Clinical samples at pre-treatment
RUIS Pre-treatment Score Distribution 
(Clinical Sample) 
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RUIS scores
N = 195; Mean 10.92; SD 3.33; Mode = 12; Median = 11
Males = 11.07; Females 10.90
Reliability Estimates RUIS
Cronbach’s Alpha
Data Source Pre-treatment Post-treatment
SAHOS all-RUIS 0.91 NA
PS Retro study NA 0 85   
(women)
.
Current Study-UI 0 73* 0 90 . .
Current Study all 0 84 0 91 - . .
*Pre-treatment alpha for UDI-6 = 0.64; ISI = 0.54
Factor Structure 
• Explains 49% of the variance – uni-dimensional
Factor
Items 1 (49%)
RUIS1-urge 0.64
RUIS2-stress 0.67
RUIS3-leak small amounts 0.80
RUIS4-leak frequency 0.72 
RUIS5-leak volume 0.64
N = 195 UI patients; replicated all patients (N =255) – variance explained 62%
Factor Structure 
RUIS: Before and After Treatment
Patient Satisfaction (PS) Study
RUIS: Before and After Treatment
Pre-Treatment Post-Treatment
At follow up the mean RUIS score was 6 95 (SD = 4 77 N = 100) For females the        . ,   . ,   .    
mean was 6.91 and for males the mean was 7.21. 
Examination of pre-post scores revealed a statistically significant improvement of 
4.07 points (SD = 4.76, N = 100) (paired t-test, t = 8.56, df = 99, p < 0.01). 
RUIS: Change with Treatment: Pre and Post cases
Study Mean SD N
PS  PRE (retro) 11.81 3.81 163
PS POST 4.93 3.94 163
Then-test mean change score 6.29 4.78 163
Current study Pre (females) 11.02 3.15 86
Current study Post (females) 6.91 4.83 86
Mean change score 4.12 4.88 86
RUIS: Change with Treatment   
Study Change type* N %
PS Retro % report improvement 144 85.7
% report no change 13 7.7
% report worse 11 6 5  .
Current Study % improved 77 77.0
% no change 5 5.0
% worse 18 18.0
Improvement = +1 or more; Worse = -1 or more
Effect of Treatment  
• For all treatment groups RUIS scores improved 
i ifi tl (4 07) ith t t ts gn can y . w  rea men
• There was a significant difference by type of 
treatment. Mean improvement for CA = 2 (n = 13); 
f Ph i th 3 09 ( 55) d f Sor ys o erapy = .  n =  an  or urgery = 
7.07 (n = 29)
• An analysis of RUIS change by Patient Global 
R ti f I t t th Ma ng o  mprovemen  sugges s e ean 
Clinically Important Difference (MCID) for patients 
is estimated at 2 RUIS change scores     . 
Associations with Other Measures
UDI-6 ISI ICIQ-UI Wei ISI IIQ PR 
Severity
CR
Severity
* All correlations p<0.01
RUIS* (Pre) 0.76 0.76 0.74 0.72 0.53 0.62 0.37
   
Clinical Severity Ratings – RUIS mean score for mild = 9.22 and for moderate and 
severe = 11.87 (F = 33.80; df 1,192; p=0.000). Patient Severity Ratings – RUIS mean 
score for mild = 8.36; moderate = 11.60; severe = 14.03 (F 58.65; df 2, 191; p=0.000)
Daily Pad Use – RUIS mean for 1 or less = 9.02, for 2 or more = 12.60 (F Welch = 
78 33; df 1 171 06; p = 0 000) Pad Use Size – RUIS mean for no/thin pad = 9 21;.   , .    . .         .  
medium pads = 12.00, large pads = 13.57 (F = 38.56; df 2, 191; p=0.000)
ICIQ number of symptoms severity index – RUIS mean scores for 2 or less 
symptoms = 8.60; 3-4 symptoms = 11.46, 5 or more symptoms = 13.21 (F Welch = 
43.84; df 2, 125.42; p=0.000)
RUIS scores were also higher for those having surgical treatment and for those            
experiencing double incontinence
Suggested Cut Points  
Based on the sample distributions and clinician and patient 
ratings the following cutpoints for interpretation are 
suggested:
• 0-3: no urinary incontinence or extremely mild or 
occasional incontinence symptoms  
• 4-8: mild urinary incontinence
• 9-12: moderate urinary incontinence  
• 13-16: severe urinary incontinence (scores of 15 -16 
could be considered very severe)    
• For screening we suggest a score of 4 would warrant 
further assessment.
RUIS: Reliable Valid and Responsive ,   
 The internal consistency reliability estimate is 
considered adequate to good for clinical samples 
(0.73 - 0.84 Pre and 0.91 Post) and better than 
other short measures UDI-6 and ISI
 Retest Reliability is good 0.80 (ICC)    
 The RUIS demonstrates good responsiveness to 
change as a result of treatment     
 The RUIS has an appropriate internal structure, 
correlates appropriatel ith other UI meas res y w    u  
and discriminates well between other clinical 
indicators of incontinence severity (validity)    
Revised Faecal Incontinence Scale   
 Do you leak, have accidents or lose control with solid 
t l? (W )s oo  exner
 Do you leak, have accidents or lose control with liquid 
stool? (Wexner) 
 Do you leak stool if you don’t get to the toilet in time?
 Does stool leak so that o ha e to change o r     y u v    y u  
underwear?
 Does bowel or stool leakage cause you to alter your          
lifestyle? (Wexner)
Response Categories: Never/ Rarely, i.e. < once in the past four 
weeks/ Sometimes, i.e. < once a week, but > once in the past four 
weeks/ Often or usually, i.e. < once a day but > once a week/ 
Always i e > once a day or whenever you have a bowel movement, . .           
Item scores range from 0-4 and the Scale Score ranges from 0-20
RFIS: Psychometric Properties & comparison with 
RUIS
Females
N Mean SD
RFIS-SAHOS 1715 0.43 1.56 0 18
Actual Range
RFIS Clin Prosp* 51 9.76 4.86 0 20
RUIS Clin Prosp* 167 10.90 3.33 3 16
N Mean SD Actual RangeMales
RFIS-SAHOS 1202 0.26 1.04 0 12
RFIS-Clin Prosp* 10 9.10 3.6 3 16
RUIS Clin Prosp* 28 11.07 3.74 0 16
* = Clinical samples at pre-treatment
RFIS Distributions 
RFIS pre-treatment scores (all)
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N = 38, Mean = 9.79, SD = 4.68 N = 38, Mean = 6.68, SD = 4.82
Faecal Incontinence
 There was a an improvement of 3.11 points (paired t-test, t = 
3.89, df = 37, p = 0.000). RFIS the most responsive measure.
No difference in improvement between surgical and       
conservative treatments – all improved. 
 The internal consistency reliability (ICR) for the RFIS pre       -
treatment is 0.78 (faecal sample). By comparison pre-treatment 
alphas for Wexner = 0.65 and St Marks = 0.66 which are 
id d i d t Th ICR f RFIS 0 91 ( ll ti t )cons ere  na equa e. e  o  = .  a  pa en s .
 Retest reliability is good = 0.80 (ICC)
 RFIS scores discriminate by clinician and patient severity 
ratings pad use and size duration of symptoms and other,    ,      
severity indices. High correlations with other FI measures. 
 Factor structure suggest RFIS is a uni dimensional scale the      -   -  
general faecal incontinence factor explains 54% of variance
RUIS & RFIS Change Scores    
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Suggested Cut Points  
Based on the sample distributions, clinician and patient 
ratings and comparison to other severity indicators the 
following cut points for interpretation are suggested      
• 0-3: no faecal incontinence or extremely mild or 
occasional incontinence symptoms  
• 4-9: mild faecal incontinence
• 10-14: moderate faecal incontinence  
• 15-20: severe urinary incontinence (scores above 16 
could be considered very severe)    
• For screening we suggest a score of 4 would warrant 
further assessment.
Conclusions
D t i di t b th th RFIS d th RUIS h a a n ca es o  e  an  e  ave 
good psychometric properties (reliability, validity) 
and are sensitive to detecting change in patients’        
incontinence status (responsiveness)
 The RUIS and RFIS are very short and simple to          
use and provide reliable estimates of the extent of 
the patient’s incontinence and the extent of their        
improvement from treatment
 Good for quality improvement - use in routine       
practice should be encouraged – an online 
collaboration?
Patient Satisfaction 
Hawthorne (2006) Review of patient satisfaction•       
measures for continence services and treatments
Reviewed instruments
• Client Satisfaction Questionnaire (CSQ-18) (Larsen, et 
al 1979) (generic).  
• Consultation Satisfaction Questionnaire (Consult SQ) 
(Baker, 1990) (generic)
• Patient Satisfaction Index (PSI) (Guyatt, et al. 1995) 
(generic)
• Genito-Urinary Treatment Satisfaction Scale (GUTSS)     
(Hawthorne and Hamer, 2000) (condition specific)
Theory
“P ti t ti f ti b id d t ba en  sa s ac on may e cons ere  o e 
one of the desired outcomes of care, even an 
element in heath status itself. An expression       
of satisfaction or dissatisfaction is also the 
patient’s judgment on the quality of care in 
all its aspects but particularly as concerns  ,     
the interpersonal process.”
(Donabedian 1998 p 1746), , . 
• Seven key domains: effectiveness, information,    
technical skill, participation, relationship, access 
& facilities, satisfaction general.
Original Patient Satisfaction Study   
P t t t t d i (Th T t P d )• os  rea men  es gn en- es  roce ure
• Survey – 4 patient satisfaction measures (CSQ-
18 Consult SQ PSI GUTSS) incontinence,  , , ,  
symptoms, plus other items about treatment 
(e.g. expectations). 
• St George Hospital, Sydney and Royal Women’s 
Hospital, Melbourne (and associated private 
clinics) 
• Women only
Urinary patients•  
• Treatments = surgery or physiotherapy
N = 178•   
Results
 An examination of the psychometric properties of the 
four instruments found some evidence of item 
redundancy, response bias and poor responsiveness.
 Non-responsive & poorly worded items were deleted 
and the remaining items (n = 49) were used to          
develop a pooled patient satisfaction estimate.
 Used Item Response Theory (IRT) to examine and 
select the items with the best fit with the pooled patient 
satisfaction estimate. In this iterative analysis we were 
looking for the best fitting model consistent with the 7 
domains of patient satisfaction A 7 item draft SAPS   .      
was developed
Summary
Th d ft SAPS h d ll t f• e ra   a  an exce en  coverage o  
patient satisfaction model and was a strong uni-
dimensional scale (Loevinger H = 0.55).     
• The draft SAPS was more sensitive than any 
other instrument to the pooled patient 
satisfaction estimate.
• Internal consistency reliability (Cronbach’s 
alpha) 0 86 = .
• The draft SAPS correlated well with other 
measures of patient satisfaction and with other       
indicators of treatment outcomes – most 
improved had higher satisfaction scores
Current Study 
• Pre and post treatment design (prospective 
study)
• Survey - continence symptoms, clinical ratings, 
q alit of life meas res and satisfaction itemsu y   u     
• Tested some changes to the wording of the 
original SAPS items e g replacing ‘how happy’   . .  
with ‘how satisfied’ for two items
• Tested the order of response categories (very       
satisfied – very dissatisfied) for some items 
• Tested some additional Qs – re success and 
outcomes of treatment, expectations and patient 
global improvement
Short assessment of patient satisfaction 
(SAPS)
Effectiveness: How satisfied are you with the effect of your        
treatment ? 
Information: How satisfied are you with the explanations the 
doctor or other health professional has given you about the 
results of your treatment ?
Technical Skill: The doctor or other health professional was        
very careful to check everything when examining you?
Participation: How satisfied were you with the choices you had 
in decisions affecting your health care ?       
Relationship: How much of the time did you feel respected by 
the doctor or other health professional ? 
Access & facilities: The time you had with the doctor or other 
health professional was too short?
Satisfaction: Are you satisfied with the care you received in the         
hospital or clinic ? 
Preliminary Data Summary Statistics 2011  –   
Study 1 SAPS Total % 
Group Mean SD N
Women - Urinary 82.52 15.12 176
Study 2 SAPS Total % 
G M SD Nroup ean
Women - Urinary 76.86 18.29 86
Men Urinary 81 11 16 07 14 - . .  
Women - Faecal 80.75 17.04 31
Men - Faecal 84 82 7 57 8 . .
All incontinence 78.43 17.32 139
Cronbach’s alpha = 0.80-0.85
SAPS Data 
Figure 2: SAPS score distribution
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0-10 very dissatisfied; 11-18 dissatisfied; 19-26 satisfied; 27-28 very         
satisfied.
Mean 21.96, SD 4.85 (N = 139 all incontinence patients)
Summary: SAPS 
• Statistically significant differences in mean SAPS      
scores by type of incontinence treatment (surgical 
patients more satisfied), clinician and patient      
rated severity at post-treatment (normal/mild more 
satisfied) and post-treatment general health     
status (fair/poor health least satisfied)
• No significant differences by gender age group    ,  , 
educational attainment or incontinence type
SAPS demonstrates good discriminant validity•     
• Easy to use for quality improvement activities
Other Activities 
• Burden of disease – UI $17 billion p.a.; FI $8 
billion p.a.- first estimates for faecal burden of 
disease
• Issue of whether you include mild cases (75%)
• Faecal Cost Of Illness – total personal costs not        
related to severity (as costs of investigation are 
fixed and uniform regardless of severity). Costs       
for pads and creams significantly related to 
severity. Total patient expense p.a. = @$609;       
total incontinence expense (patient, health fund 
and govt. = @1,400 p.a. per patient.)      
IMPACT
SF-36 Profiles Scores at Pre-treatment
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Recommendations
• Facilitate use in routine practice with an online 
collaboration – outcomes monitoring
• Online collaboration – patient management and 
monitoring - can also address research gaps
• Cultural adaptation of tools needed for those from 
indigenous and CALD backgrounds; proxy 
versions for children and frail elderly
• ALSWH – 5000 cases, now 2 time points for RUIS 
– worthwhile to analyse this data
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3 Month Follow-Up Report
Name: (blank)
Date: 08/08/2011
Number of bad pain days last week: 0 days
Hours of bad pain on those days: 0 hours
H ld i t thi t? (0 t 10 ) 4ow wou  you assess your pa n now, a  s momen   - none o  - max
How strong was the strongest pain durng the past 4 weeks? (0 - none to 10 - max) 5
How strong was the pain during the past 4 weeks on average? (0 - none to 10 - max) 4
Your pain at its least in the past 4 weeks: 3
(0 = No Pain & 10 = Pain as bad as you can imagine)
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3 month follow up
What’s happened?
Canberra Hospital
W t d H it les mea  osp a
Royal Brisbane Hospital
Best method to wean stable pre-term babies off Continuous Positive Airway 
Pressure (CPAP)
• Used DQ’s randomisation module in the scientific tool kit
• Results:
Most unexpected method (basically straight off CPAP) produced:       
 3 times less Chronic Lung Disease (9% vs 30%) 
 2 weeks on average less time in hospital 
 DRG $ saving of $7 000 per baby at TCH or    ,       
 $504,000 per year at TCH 
 Peer review publication in train
 Guidelines are now being developed
 Long–term cohort study, with nested RTCs next step
 Savings multiplied if across sites
Benchmarking
Clinic Type RUIS Pre RUIS Post RUIS Change
1 Conservative
(9 = CA)
Mean 10.20 7.70 2.50
N 10 10 10
Std. Deviation 2.78 4.67 3.57
Imagine a 
much larger 
sample..
2 Physio Mean 10.92 8.03 2.89
N 36 36 36
Std. Deviation 3.38 4.61 4.01
3 Surgery Mean 11.07 5.29 5.79
N 14 14 14
Std. Deviation 3.56 4.73 5.79
4 Conservative
(CA = 6
Mean 11.46 10.15 1.31
N 13 13 13PH = 7)
Std. Deviation 3.36 3.28 2.81
5 Surgery Mean 12.00 3.73 8.27
N 15 15 15
Std. Deviation 2.04 5.44 5.66
6 Physio Mean 10.88 5.25 5.63
N 8 8 8
Std. Deviation 2.42 1.83 3.11
Total Mean 11.10 6.98 4.13
N 96 96 96
Std. Deviation 3.07 4.81 4.84
